On April 26, 2021 Lantern Pharma (NASDAQ: LTRN), a clinical stage biopharmaceutical company using its proprietary RADR artificial intelligence ("A.I.") platform to improve drug discovery and development, and identify patients who will benefit from its portfolio of targeted oncology therapeutics, reported that it will host a conference call and live webcast on Monday, May 3, 2021 at 4:30 p.m. Eastern Time to discuss financial and operating results for the first quarter ended March 31, 2021 (Press release, Lantern Pharma, APR 26, 2021, View Source [SID1234578503]). The call will be led by Panna Sharma, President and Chief Executive Officer. He will be joined on the call by other members of the management team.
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Conference Call
Toll-free US and Canada: 800–791–4813 – conference ID 97381
US and Canada callers one touch dial: +1.800.791.4813,,97381#
International: 785–424–1102 – conference ID 97381
Replay Number: 1-800-839–8389, no passcode. Available through 11:59 pm ET on June 3, 2021.
Webcast
Live webcast will be available at: View Source
The webcast will be archived on View Source through 11:59 pm ET on June 3, 2021.